Pembrolizumab and lenalidomide induced remission in refractory double-hit lymphoma
Crossref DOI link: https://doi.org/10.1007/s00277-016-2771-2
Published Online: 2016-07-30
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chan, Thomas S. Y.
Khong, Pek-Lan
Kwong, Yok-Lam
License valid from 2016-07-30
